Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Accardo Palumbo, Antonina ^a   Giardina, Anna Rita ^a   Ciccia, Francesco ^a   Ferrante, Angelo ^a   Principato, Alfonso ^a   Impastato, Rosalia ^a   Giardina, Ennio ^a   Triolo, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CORTICOSTEROID; GAMMA INTERFERON; GRANZYME A; INFLIXIMAB; PERFORIN; TUMOR NECROSIS FACTOR RECEPTOR 2; ANTIRHEUMATIC AGENT; GRANZYME; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BEHCET DISEASE; CELL CULTURE; CELL EXPANSION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; LOW DRUG DOSE; MALE; PHENOTYPE; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ADOLESCENT; AGED; CASE CONTROL STUDY; CELL PROLIFERATION; CELL SURVIVAL; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; BEHCET SYNDROME; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FEMALE; GRANZYMES; HUMANS; INTERFERON-GAMMA; MIDDLE AGED; PERFORIN; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTES; YOUNG ADULT;

EID: 77953013515     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3043     Document Type: Article

References (27)

1. Pipitone N, Olivieri I, Cantini F, Triolo G, Salvarani C. New approaches in the treatment of Adamantiades-Behçet's disease. Curr Opin Rheumatol 2006, 18:3-9. 10.1097/01.bor.0000197995.27579.9b, 16344613.
2. Giardina A, Ferrante A, Ciccia F, Vadalà M, Giardina E, Triolo G. One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs. Rheumatol Int 2009,
3. Kahan A, Hamzaoui K, Ayed K. Abnormalities of T lymphocyte subsets in Behçet' s disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. J Rheumatol 1992, 19:742-746.
4. Triolo G, Accardo-Palumbo A, Dieli F, Ciccia F, Ferrante A, Giardina E, Licata G. Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease. Ann Rheum Dis 2002, 61:459-462. 10.1136/ard.61.5.459, 1754076, 11959773.
5. Todaro M, Zerilli M, Triolo G, Iovino F, Patti M, Accardo-Palumbo A, di Gaudio F, Turco MC, Petrella A, de Maria R, Stassi G. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins. Arthritis Rheum 2005, 52:2179-2191. 10.1002/art.21145, 15986355.
6. Triolo G, Accardo-Palumbo A, Dieli F, Ciccia F, Ferrante A, Giardina E, Sano CD, Licata G. Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and humour necrosis factor receptor II and interleukin-12 receptor B1 expression in active disease. Arthritis Res Ther 2003, 5:R262-R268. 10.1186/ar785, 193723, 12932289.
7. Accardo-Palumbo A, Ferrante A, Cadelo M, Ciccia F, Parrinello G, Lipari L, Giardina AR, Riili M, Giardina E, Dieli F, Triolo G. The level of soluble Granzyme A is elevated in the plasma and in the Vgamma9/Vdelta2 T cell culture supernatants of patients with active Behçet's disease. Clin Exp Rheumatol 2004, 22:S45-S49.
8. Criteria for diagnosis of Behçet' s disease. International Study Group for Behçet's Disease. Lancet 1990, 335:1078-1080.
9. Bahcta BB, Brennan P, James TE, Chamberlain A, Noble BA, Silman AJ. Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology 1999, 38:728-735. 10.1093/rheumatology/38.8.728, 10501420.
10. Lawton G, Bahcta BB, Chamberlain AA, Tennant A. The Behçet's disease activity index. Rheumatology 2004, 43:73-78. 10.1093/rheumatology/keg453, 12890862.
11. Jabs DA, Nussenblatt RB, Rosenbaum JT, . Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophtalmol 2005, 140:509-516. 10.1016/j.ajo.2005.01.035, 16196117, Standardization of Uveitis Nomenclature (SUN) Working Group.
12. Hamzaoui K, Kahan A, Ayed K, Hamza M. Cytotoxic T cells against herpes simplex virus in Behçet's disease. Clin Exp Immunol 1990, 81:390-395. 10.1111/j.1365-2249.1990.tb05344.x, 1534992, 2168823.
13. Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL-6 and interferon-gamma by T cells from patients with Behçet's disease. Cell Immunol 1992, 140:410-419. 10.1016/0008-8749(92)90207-6, 1544169.
14. Takeno M, Kaiyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995, 38:426-433. 10.1002/art.1780380321, 7880197.
15. Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Ciccia F, Giardina E, Triolo G. Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease. Clin Exp Rheumatol 2000, 18:495-498.
16. Triolo G, Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Giardina E. Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and myeloperoxidase levels. Clin Immunol 1999, 91:330-337. 10.1006/clim.1999.4687, 10370379.
17. Sakane T, Kotani H, Takada S, Tsunematsu T. Functional aberration of T cell subsets in patients with Behçet's disease. Arthritis Rheum 1982, 25:1343-1351. 10.1002/art.1780251110, 6215926.
18. Yamashita N, Kaneoka H, Nanako S, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T. Role of gammadelta T lymphocytes in the development of Behçet's disease. Clin Exp Immunol 1997, 107:241-247. 10.1111/j.1365-2249.1997.274-ce1159.x, 1904583, 9030859.
19. Freysdottir J, Lau S, Fortune F. γδ T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 1999, 118:451-457. 10.1046/j.1365-2249.1999.01069.x, 1905456, 10594567.
20. Spinozzi F, Agea E, Bistoni O, Travetti A, Migliorati G, Moraca R, Nicoletti I, Riccardi C, Paoletti FP, Vaccaro R, et al. T lymphocytes bearing the gamma delta T cell receptor are susceptible to steroid-induced programmed cell death. Scand J Immunol 1995, 41:504-508. 10.1111/j.1365-3083.1995.tb03599.x, 7725070.
21. Lin T, Matsuzaki G, Umesue M, Omoto K, Yoshida H, Harada M, Singaram C, Hiromatsu K, Nomoto K. Development of TCR-gamma delta CD4-CD8+ alpha alpha but not TCR-alpha beta CD4-CD8+ alpha alpha i-IEL is resistant to cyclosporin A. J Immunol 1995, 155:4224-4230.
22. Accardo-Palumbo A, Ferrante A, Ciccia F, Cadelo M, Giardina AR, Impastato R, Triolo G. Pentoxifylline inhibits Vgamma9/Vdelta2 T lymphocyte activation of patients with active Behçets disease in vitro. Int J Immunopathol Pharmacol 2007, 20:601-606.
23. Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C. Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet' disease: a comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993, 20:1544-1549.
24. Saynalp N, Ozcebe OL, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S. Cytokines in Behçet's disease. J Rheumatol 1996, 23:321-322.
25. Ueta C, Kawasumi H, Fujiwarw H. Interleukin-12 activates human γ/δ T cells: synergistic effect of tumor necrosis factor-α. Eur J Immunol 1996, 26:3066-3073. 10.1002/eji.1830261237, 8977306.
26. Elezoglou AV, Sfikakis PP, Vaiopoulos G, Kapsimali V, Kaklamanis PG. Serum levels of soluble TNF-alpha receptor-II (P75), circulating gammadelta T-cells and Adamantiades-Behçet's disease activity. Adv Exp Med Biol 2003, 528:261-265. full_text, 12918703.
27. Li H, Luo K, Pauza CD. TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells. J Immunol 2008, 181:7131-7137.